1. Home
  2. MRVI vs KLTR Comparison

MRVI vs KLTR Comparison

Compare MRVI & KLTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRVI
  • KLTR
  • Stock Information
  • Founded
  • MRVI 2014
  • KLTR 2006
  • Country
  • MRVI United States
  • KLTR United States
  • Employees
  • MRVI 560
  • KLTR N/A
  • Industry
  • MRVI Biotechnology: Pharmaceutical Preparations
  • KLTR EDP Services
  • Sector
  • MRVI Health Care
  • KLTR Technology
  • Exchange
  • MRVI Nasdaq
  • KLTR Nasdaq
  • Market Cap
  • MRVI 350.1M
  • KLTR 302.6M
  • IPO Year
  • MRVI 2020
  • KLTR 2021
  • Fundamental
  • Price
  • MRVI $2.42
  • KLTR $1.63
  • Analyst Decision
  • MRVI Hold
  • KLTR Buy
  • Analyst Count
  • MRVI 10
  • KLTR 3
  • Target Price
  • MRVI $5.84
  • KLTR $2.83
  • AVG Volume (30 Days)
  • MRVI 1.5M
  • KLTR 277.5K
  • Earning Date
  • MRVI 08-11-2025
  • KLTR 08-07-2025
  • Dividend Yield
  • MRVI N/A
  • KLTR N/A
  • EPS Growth
  • MRVI N/A
  • KLTR N/A
  • EPS
  • MRVI N/A
  • KLTR N/A
  • Revenue
  • MRVI $219,830,000.00
  • KLTR $181,350,000.00
  • Revenue This Year
  • MRVI N/A
  • KLTR $3.43
  • Revenue Next Year
  • MRVI $7.23
  • KLTR $2.96
  • P/E Ratio
  • MRVI N/A
  • KLTR N/A
  • Revenue Growth
  • MRVI N/A
  • KLTR 2.56
  • 52 Week Low
  • MRVI $1.67
  • KLTR $1.06
  • 52 Week High
  • MRVI $9.60
  • KLTR $2.82
  • Technical
  • Relative Strength Index (RSI)
  • MRVI 49.60
  • KLTR 48.46
  • Support Level
  • MRVI $2.28
  • KLTR $1.38
  • Resistance Level
  • MRVI $2.47
  • KLTR $1.66
  • Average True Range (ATR)
  • MRVI 0.14
  • KLTR 0.09
  • MACD
  • MRVI -0.01
  • KLTR 0.02
  • Stochastic Oscillator
  • MRVI 27.45
  • KLTR 85.71

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About KLTR Kaltura Inc.

Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and at school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments which are Enterprise, Education, and Technology, and Media and Telecom. The majority of the revenue is derived from Enterprise, Education & Technology. The majority of the revenue is earned from the United States.

Share on Social Networks: